Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Next Post S&P 500 Rises from Bearish to Neutral, But Will It Last? April 28, 2025 Related Posts International Lithium Announces Upsize and Extension of Private Placement May 2, 2025 xU3O8 (uranium.io): Pioneering Physical Uranium Ownership Powered by Blockchain Technology May 2, 2025 Trump Administration Strikes 50/50 Minerals Deal with Ukraine May 2, 2025
xU3O8 (uranium.io): Pioneering Physical Uranium Ownership Powered by Blockchain Technology May 2, 2025